InvestorsHub Logo
Followers 3
Posts 934
Boards Moderated 0
Alias Born 03/30/2021

Re: None

Thursday, 01/20/2022 4:36:25 PM

Thursday, January 20, 2022 4:36:25 PM

Post# of 5271

I like AXIM at these prices. I bought more today.

The FDA approved Dry Eye Disease tests are reason enough to buy AXIM at these prices. Sales of DED tests are supposed to start in Q1 2022.

Much less risk in buying AXIM at these prices when AXIM owns 2 FDA Approved + Insurance reimbursable Dry Eye Disease tests. DED sales = RISK Management.

Much more risk in buying AXIM when #ImmunoPass was their only product and ImmunoPass has no approvals to sell anywhere.
RISK: NO FDA Approval
RISK: NO Europe CE Approval
RISK: NO Approval anywhere.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News